| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| QARZIBA 4,5 mg/ml | DINUTUXIMAB BETA | CONC. PT. SOL. PERF. | L01FX06 | W70302001 | RECORDATI NETHERLANDS B.V. - OLANDA | X | |||||
| QDENGA | VACCIN TETRAVALENT DENGUE VIU, ATENUAT | PULB+SOLV. PT. SOL. INJ. | J07BX04 | W71966001 | TAKEDA PHARMACEUTICALS INTERNATIONAL AG - IRLANDA | X | |||||
| QDENGA | VACCIN TETRAVALENT DENGUE VIU, ATENUAT | PULB+SOLV. PT. SOL. INJ. | J07BX04 | W71966002 | TAKEDA PHARMACEUTICALS INTERNATIONAL AG - IRLANDA | X | |||||
| QDENGA | VACCIN TETRAVALENT DENGUE VIU, ATENUAT | PULB.+SOLV. PT. SOL. INJ. IN SERINGA PREUMPLUTA | J07BX04 | W71967001 | TAKEDA PHARMACEUTICALS INTERNATIONAL AG - IRLANDA | X | |||||
| QDENGA | VACCIN TETRAVALENT DENGUE VIU, ATENUAT | PULB.+SOLV. PT. SOL. INJ. IN SERINGA PREUMPLUTA | J07BX04 | W71967002 | TAKEDA PHARMACEUTICALS INTERNATIONAL AG - IRLANDA | X | |||||
| QDENGA | VACCIN TETRAVALENT DENGUE VIU, ATENUAT | PULB.+SOLV. PT. SOL. INJ. IN SERINGA PREUMPLUTA | J07BX04 | W71967003 | TAKEDA PHARMACEUTICALS INTERNATIONAL AG - IRLANDA | X | |||||
| QDENGA | VACCIN TETRAVALENT DENGUE VIU, ATENUAT | PULB.+SOLV. PT. SOL. INJ. IN SERINGA PREUMPLUTA | J07BX04 | W71967004 | TAKEDA PHARMACEUTICALS INTERNATIONAL AG - IRLANDA | X | |||||
| QINLOCK 50 mg | RIPRETINIBUM | COMPR. | L01EX19 | W70103001 | DECIPHERA PHARMACEUTICALS (NETHERLANDS) B.V. - TARILE DE JOS | X | |||||
| QLAIRA | COMBINATII (ESTRADIOLUM VALERAT+DIENOGESTUM) | COMPR. FILM. | G03AB08 | W63889001 | BAYER AG - GERMANIA | ||||||
| QLAIRA | COMBINATII (ESTRADIOLUM VALERAT+DIENOGESTUM) | COMPR. FILM. | G03AB08 | W63889002 | BAYER AG - GERMANIA | ||||||
| QLAIRA | COMBINATII (ESTRADIOLUM VALERAT+DIENOGESTUM) | COMPR. FILM. | G03AB08 | W63889003 | BAYER AG - GERMANIA | ||||||
| QSIVA 11,25 mg/69 mg | COMBINATII (PHENTERMINUM+TOPIRAMATUM) | CAPS. CU ELIB. MODIF. | A08AA51 | W70854001 | VIVUS BV - TARILE DE JOS | ||||||
| QSIVA 11,25 mg/69 mg | COMBINATII (PHENTERMINUM+TOPIRAMATUM) | CAPS. CU ELIB. MODIF. | A08AA51 | W70854002 | VIVUS BV - TARILE DE JOS | ||||||
| QSIVA 15 mg/92 mg | COMBINATII (PHENTERMINUM+TOPIRAMATUM) | CAPS. CU ELIB. MODIF. | A08AA51 | W70855001 | VIVUS BV - TARILE DE JOS | ||||||
| QSIVA 15 mg/92 mg | COMBINATII (PHENTERMINUM+TOPIRAMATUM) | CAPS. CU ELIB. MODIF. | A08AA51 | W70855002 | VIVUS BV - TARILE DE JOS | ||||||
| QSIVA 3,75 mg/23 mg | COMBINATII (PHENTERMINUM+TOPIRAMATUM) | CAPS. CU ELIB. MODIF. | A08AA51 | W70852001 | VIVUS BV - TARILE DE JOS | ||||||
| QSIVA 3,75 mg/23 mg | COMBINATII (PHENTERMINUM+TOPIRAMATUM) | CAPS. CU ELIB. MODIF. | A08AA51 | W70852002 | VIVUS BV - TARILE DE JOS | ||||||
| QSIVA 7,5 mg/46 mg | COMBINATII (PHENTERMINUM+TOPIRAMATUM) | CAPS. CU ELIB. MODIF. | A08AA51 | W70853001 | VIVUS BV - TARILE DE JOS | ||||||
| QSIVA 7,5 mg/46 mg | COMBINATII (PHENTERMINUM+TOPIRAMATUM) | CAPS. CU ELIB. MODIF. | A08AA51 | W70853002 | VIVUS BV - TARILE DE JOS | ||||||
| QTERN 5 mg/10 mg | COMBINATII (SAXAGLIPTINUM+DAPAGLIFLOZINUM) | COMPR. FILM. | A10BD21 | W63069001 | ASTRA ZENECA AB - SUEDIA | X |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman